Which vaccines are in use in South Africa and how does our vaccination schedule measure up to international standards? In this #InTheSpotlight special briefing, Catherine Tomlinson unpacks the recent history and details the vaccines currently being used in the country.
The South African Health Products Regulatory Authority, with the South African Pharmacy Council, recently announced what was described as a crackdown on a compounding pharmacy. They allege “critical regulatory non-compliance” in relation to the compounding of unregistered medicines. In his latest Inside The Box column, Dr Andy Gray provides some background to the issues at stake, while recognising that some key elements remain contested.
On June 5 2026, an HIV prevention injection will for the first time become available at some of South Africa’s public sector clinics. In this Spotlight special briefing, Marcus Low and Elri Voigt pull together all you need to know about this “breakthrough” jab.
We can generally trust that the medicines we buy at pharmacies contain what they are supposed to and that they were manufactured according to good quality standards. In his latest column, Dr Andy Gray zooms in on the regulatory scaffolding that enables this trust.
The sale of illegal medicines is a significant threat to public safety. In his latest Inside The Box column, Dr Andy Gray asks whether the South African Health Products Regulatory Authority has the necessary tools at hand to provide protection in this area.
Although TB can be cured, it is still spreading in South Africa at alarming rates. One reason could be that some people with TB disease but without TB symptoms may unknowingly be passing on the bug. In this Spotlight special briefing, Elri Voigt unpacks what we do and do not know about asymptomatic TB.
In South Africa, as in many places, pharmaceutical companies are not free to change medicine prices as they wish. In his latest Inside The Box column, Dr Andy Gray unpacks how medicines prices are regulated in the country and considers how this regulatory framework might change.
There has been much confusion and misunderstandings about how cannabis and associated products are regulated in South Africa, with government’s own missteps adding to the uncertainty. In his last Inside The Box column for the year, Dr Andy Gray clearly sets out the current legal and regulatory situation and where we’re heading.
It is estimated that around half a million people living with HIV in South Africa don’t know they are living with the virus. One way to help these people is by offering them the means to test themselves in the privacy of their own homes. As Catherine Tomlinson explains in this Spotlight special briefing, such self-screening tests are part of our HIV response on paper, but in reality, the tests are massively underutilised.
Childhood immunisation programmes have saved many millions of lives and prevented much suffering. Yet, immunisation programmes have lost momentum over the last decade or so. In this Spotlight special briefing, Elri Voigt unpacks the available data and considers how immunisation efforts might be revitalised.
In several countries, the public is given an opportunity to share their views with regulators before new medicines are registered or to engage with those choosing essential medicines. In South Africa, however, opportunities for such public participation remains limited. In his latest Inside The Box column, Dr Andy Gray takes a look at how public participation is handled elsewhere and how it could be improved here.
Rather than trying to do everything from scratch, medicines regulators from different countries are increasingly sharing the load between them by ‘relying’ on each other’s work. In his latest Inside The Box column, Dr Andy Gray explains how such ‘reliance mechanisms’ can help regulators make decisions more quickly and efficiently, and digs into the details of how South Africa can make the most of these mechanisms.